Is BioCryst Pharmaceuticals, Inc. BCRX stock halal to invest in?

No, as of February 2026, BioCryst Pharmaceuticals, Inc. stock (BCRX) is currently categorized as NOT Shariah Compliant. The company's status is determined by a rigorous financial screening process, which uses the criteria set by the AAOIFI (Accounting and Auditing Organization for Islamic Financial Institutions) as the primary global standard for Islamic investing. BioCryst Pharmaceuticals, Inc. has been assessed to have exceeded the permissible financial thresholds—specifically in areas like interest-bearing debt or non-permissible income (such as income from interest)—and, therefore, does not qualify as a halal investment under the current review. For investors seeking Shariah compliant global stocks, it is essential to check the latest compliance status, as these screenings are updated regularly (e.g., monthly) or upon the release of new financial reports. You can find the most current status for BioCryst Pharmaceuticals, Inc. and alternative halal stock options within the Tabadulat app.

How often is BioCryst Pharmaceuticals, Inc. BCRX reviewed for Shariah compliance?

At Tabadulat, we receive Shariah compliance data on BioCryst Pharmaceuticals, Inc. BCRX monthly. We apply the rigorous AAOIFI screening methodology under the direct supervision of our dedicated Shariah Supervisory Board to ensure your investments are consistently compliant.

Does BioCryst Pharmaceuticals, Inc. BCRX pass the AAOIFI Non Permissible Income criteria?

Yes, as of February 2026, BioCryst Pharmaceuticals, Inc. stock (BCRX) passes the AAOIFI Non Permissible Income criterion. The company's income from non-permissible sources, such as interest, is below the acceptable threshold set by AAOIFI.

Does BioCryst Pharmaceuticals, Inc. BCRX pass the AAOIFI Interest Bearing Investments criteria?

Yes, as of February 2026, BioCryst Pharmaceuticals, Inc. stock (BCRX) passes the AAOIFI Interest Bearing Investments criterion. The company's interest-bearing investments are below the acceptable threshold set by AAOIFI.

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

No, as of February 2026, BioCryst Pharmaceuticals, Inc. stock (BCRX) does not pass the AAOIFI Interest Bearing Debt criterion. The company's interest-bearing debt has exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

English

العربية

Be the First to Know!

Join our waitlist for exclusive early access to Tabadulat’s Shariah-compliant trading platform. Get notified as soon as we go live and start investing with confidence.

BioCryst Pharmaceuticals, Inc.

NASDAQ

Shariah-Compliant

Not Shariah

BCRX

About

BioCryst Pharmaceuticals, Inc.

BCRX

BioCryst Pharmaceuticals Inc. is a biotechnology company that focuses on the discovery and development of novel, oral, small-molecule medicines intended to treat rare diseases. Renowned for its innovative approach, BioCryst aims to address unmet medical needs by leveraging its unique expertise in structure-based drug design. The company's flagship products target specific conditions for which there are limited or no existing therapeutics, primarily influencing the fields of immunology and hematology. BioCryst Pharmaceuticals operates within the burgeoning biotech sector, a critical area of the healthcare industry known for its expansive growth potential and frequent scientific advancements. As a player in the specialized field of rare disease treatment, BioCryst contributes significantly to the medical landscape by offering targeted solutions for patients who often have limited options. The company’s dedication to developing accessible and effective treatments positions it as an essential actor in enhancing healthcare outcomes, showcasing its market significance in bringing impactful therapies to those who need them the most.

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Employees:

580

Website:

https://www.biocryst.com

BCRX

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Sign Up.

Begin by creating your Tabadulat account. Simply enter your details and complete the verification process. You’ll be up and running in no time.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Step 4

Trade.

Once you’ve chosen the right stocks, simply place your trades. Our platform offers real-time market data and seamless execution.

Mobile screen showing investment portfolio with $100,000 total value, $48,000 invested, and a $2,000 return (4.50%) with a line graph and options for 1W, 1M, 3M, YTD, 1Y, Max, plus Trade and Deposit buttons.

Step 5

Track.

Track your Portfolio and monitor your investments with our easy-to-use dashboard. View your portfolio performance, manage assets, and make adjustments as needed.

Step 6

Withdraw.

When you're ready, withdraw your funds quickly and securely to your bank account.

BioCryst Pharmaceuticals, Inc.

About

BioCryst Pharmaceuticals, Inc.

BCRX

Frequently asked questions

Is BioCryst Pharmaceuticals, Inc. BCRX stock halal to invest in?

How often is BioCryst Pharmaceuticals, Inc. BCRX reviewed for Shariah compliance?

Does BioCryst Pharmaceuticals, Inc. BCRX pass the AAOIFI Non Permissible Income criteria?

Does BioCryst Pharmaceuticals, Inc. BCRX pass the AAOIFI Interest Bearing Investments criteria?

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

How do I buy BioCryst Pharmaceuticals, Inc. BCRX stock?

Sign Up.

Deposit.

Screen.

Trade.

Track.

Withdraw.